Status
Conditions
Treatments
About
This study called "Peers plus mobile App for Treatment in HIV (PATH)" is a two-arm randomized controlled trial (RCT) evaluating the efficacy of an intervention that combines peer navigation and mobile health (mHealth) technology to support HIV care outcomes among Hispanic and Black Persons Living with HIV (HBPLH).
Full description
PATH is a community-academic collaboration with a federally qualified health center serving patients in South San Diego under the Ryan White model of care.
The scientific premise of this RCT is that combining two interventions developed by this team (peer navigation + mHealth) into a single mHealth peer navigation intervention (PATH) will eliminate the need for in-person support from peer navigators, promote high impact on HIV care continuum outcomes, as well as extend broader reach to underserved communities.
The RCT will test the efficacy of PATH with 375 HBPLH (among whom >33% will report stimulant and/or opioid use in the past 6 months).
Aim 1. Improve the primary outcomes - sustained viral suppression (i.e., suppressed viral load at both 6- and 12-month follow-up), and secondary outcomes (e.g., retention in care) compared to usual care.
Sub-aim 1: Explore subgroup differences in efficacy based on factors like race/ethnicity and substance use.
Aim 2. Examine the theory-informed mediators (e.g., self-efficacy to engage in HIV care, HIV stigma) through which PATH has the greatest impact on sustained viral suppression among HBPLH.
Aim 3. Explore whether PATH significantly affects substance-related outcomes (e.g., frequency of substance use, engagement in substance abuse treatment) when compared to usual care among those using substances (i.e., stimulants and/or opioids).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
≥18 years old
Can read and speak English or Spanish
Self-reported diagnosis of HIV by a physician or healthcare provider
Currently prescribed HIV medication
Having access to an internet browser on a home computer, tablet, or smart phone
Does not plan to move out of the San Diego area in the next 12 months
Meets one or more of the following medical chart verified or self-reported criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
309 participants in 2 patient groups
Loading...
Central trial contact
Megan Liang, MPP; Eileen Pitpitan, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal